Ocular Inflammation

Last medically reviewed: October 7, 2026

⚠ Important — educational information only, not medical advice

EyeCyte provides educational and scientific information and does not provide medical advice, diagnosis, or treatment. Emerging regenerative and biologic technologies discussed on this website may be experimental, investigational, unapproved, or supported only by preclinical evidence. Patients should discuss medical decisions with appropriately licensed healthcare professionals.
Not an FDA-approved treatment unless explicitly stated. Except where a page names an FDA-approved product, the stem-cell, MSC, exosome, extracellular-vesicle, Wharton’s jelly and other biologic approaches described here are not FDA-approved for any eye condition. Research findings — especially laboratory and animal studies — are not proof that anything works or is safe in people.
Research-Use-Only (RUO): Research-Use-Only (RUO) materials referenced on EyeCyte are for laboratory research by qualified professionals only. They are not drugs, biologics or devices approved for human use, are not intended for administration to people, and are not intended to diagnose, treat, cure, mitigate or prevent any disease.
EyeCyte does not sell, offer, recommend or refer for treatment. Be cautious of any clinic offering unapproved stem-cell or biologic injections for the eye; the FDA has warned of serious harm, including blindness.

Full medical disclaimer · RUO policy · Medical review policy

Inflammation contributes to many eye diseases, from uveitis to dry eye and diabetic retinopathy.

Research is not treatment. The studies summarized below are investigational. They are presented for education only, do not show that any approach is safe or effective in patients, and are not a recommendation. Unless stated as FDA-approved, none of these approaches is approved for this condition. RUO materials are not for human use.

Research directions

Immune signaling, the complement system (relevant to geographic atrophy), and immunomodulation by MSC-derived factors in animal models.^[1]

Answers

What is ocular inflammation in eye disease research?

Related conditions

Diabetic Retinopathy & Diabetic Macular Edema Dry Eye Disease Uveitis & Ocular Inflammation Age-Related Macular Degeneration Limbal Stem Cell Deficiency & Corneal Damage

Patients

Discuss medical decisions with a licensed eye-care professional.

Find an Eye-Care Professional →

Professionals

Scientific education and research resources.

For Providers — Get More Information →

References

FDA Approves First Treatment for Geographic Atrophy, a Leading Cause of Blindness (pegcetacoplan). U.S. Food and Drug Administration, 2023. [Regulator · citation details pending reviewer confirmation]